v3.26.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 32,425 $ 74,603
Marketable securities, current 172,973 173,934
Accounts receivable 1,405 2,401
Prepaid expenses and other current assets 7,699 7,172
Total current assets 214,502 258,110
Marketable securities, non-current 69,289 48,563
Property and equipment, net 3,829 4,744
Right-of-use asset 36,170 40,532
Restricted cash 3,443 3,443
Other assets 4,567 3,683
Total assets 331,800 359,075
Current liabilities:    
Accounts payable 963 858
Accrued expenses and other current liabilities 14,142 13,314
Deferred revenue, current 19,516 12,493
Operating lease liability, current 6,839 6,367
Total current liabilities 41,460 33,032
Deferred revenue, net of current 13,765 15,841
Operating lease liability, net of current 48,407 53,615
Total liabilities 103,632 102,488
Commitments and contingencies (see Note 12)
Stockholders’ equity:    
Preferred stock, par value of $0.0001 per share; 10,000,000 shares authorized, and no shares issued or outstanding as of September 30, 2026 and December 31, 2025 0 0
Common stock, par value of $0.0001 per share; 300,000,000 shares authorized as of September 30, 2026 and December 31, 2025, and 131,309,208 and 96,914,418 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively 13 9
Additional paid-in capital 1,038,518 995,221
Accumulated other comprehensive income (loss) (1,063) 50
Accumulated deficit (809,300) (738,693)
Total stockholders’ equity 228,168 256,587
Total liabilities and stockholders’ equity $ 331,800 $ 359,075
Common stock, shares authorized (in shares) 300,000,000 300,000,000